Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

utions received a major boost. While all three of our in-clinic molecules performed admirably, Btk Inhibitor PCI-32765 was in all forms of measurement truly outstanding. We plan to initiate our first Phase III trial for 32765 in this fiscal year ending June 30, 2012. We currently also plan to initiate a second Phase III during calendar year 2012. In terms of human and financial capital we are in good shape. Opportunity attracts great people and so it is the case with us. Our expanding team continues to be very focused on building a viable pharmaceutical company that makes a truly significant difference for the better." said Bob Duggan, CEO and Chairman of the Board. "We at Pharmacyclics take great pride in our accomplishments over the past few years and we maintain a keen sense of obligation and enthusiasm as we create our future."

Recent Developments & HighlightsBruton's Tyrosine Kinase (Btk) Inhibitor for Oncology

  • Results from our Phase IB/II trial of PCI 32765 in chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) were presented at an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois in June 2011. As reported at the meeting, treatment with PCI-32765 was generally well-tolerated.  The most common adverse events were Grade 1 (mild) or Grade 2 (moderate) diarrhea, fatigue, and nausea. Durable anti-tumor activity was also observed; 3 of 83 patients who were evaluable at the time of presentation had experienced disease progression.  An abstract with an updated analysis of this trial has been submitted for the 2011 American Society of Hematology (ASH) Annual Meeting to be held in San Diego in December, 2011.

  • In August 2011, we entered into a five-year Cooperative Research and Development Agreement with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765.  Under the Agreement, the NCI's Division of Cancer
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
    2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
    3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
    4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
    5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
    6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
    7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
    8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
    9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
    10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
    11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 19, 2014 Research ... the addition of the "Global Gynecological ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... classified into wide categories based on their ... treatment of different gynecological conditions that affect ...
    (Date:9/19/2014)... CHICAGO , Sept. 19, 2014  4WEB Medical ... of 3D-printed foot and ankle osteotomy implants on ... and Ankle Society annual meeting in Chicago ... for all of a surgeon,s osteotomy needs with 74 size ... wedge systems had smaller offerings of only 15 to 18 ...
    (Date:9/19/2014)... , Sept. 19, 2014 UBM Medica US ... leading online community to help oncologists and other clinicians ... regarding the use of targeted therapies and immunotherapies, discusses ... and treatment.  Every September, Blood ... to raise awareness about blood cancers—helping to increase survival ...
    Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
    ... Journal of Medicine Study Questions Value of Knee ... new study,questioning the usefulness of arthroscopic surgery for ... physical therapy as an,effective non-surgical option, according to ... published in the September 11 issue of,the New ...
    ... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates,for central nervous system disorders, reported today ... 2008 and discuss the iloperidone non-approvable action,letter that ... Vanda presented arguments to support its belief that ...
    Cached Medicine Technology:New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 2New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 3Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
    (Date:9/21/2014)... (PRWEB) September 21, 2014 The Laboratory ... businesses and manufacturers perform tests on items ranging from ... increasingly regulated society, pressure on operators to ensure the ... ever. A greater number of government safety regulations and ... goods prior to sale. Although revenue briefly dipped in ...
    (Date:9/21/2014)... why cancer cells metastasize? Think of Sparta. , Ancient ... prepared them for the demands of battle on distant ... thing according to a new study revealing previously unknown ... the original tumor site, and those that travel to ... ability to metastasize is the primary cause of cancer-related ...
    (Date:9/21/2014)... 21, 2014 (HealthDay News) -- Young women starting college ... which foods they should eat. But they aren,t confident ... according to a new study. The study ... of Illinois,s Peer Education Exercising and Eating Right program. ... they choose to eat if they were very busy ...
    (Date:9/21/2014)... 2014 To accommodate the ever-growing customer ... provide more trendy items. Recently, the company has unveiled ... the new and elegant wedding gowns, Angeldress.co.uk wants to ... need in an easy way. Its high quality vintage ... from 12% off to 62% off. , Online shopping ...
    (Date:9/21/2014)... Recently, BambooIndustry.com, an experienced producer of natural ... bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels ... are available at discounted prices now, from 10 to ... bamboo panels are available in many specifications; they ... of them is finely manufactured by qualified workers. They ...
    Breaking Medicine News(10 mins):Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
    ... Finding is good news for first-line treatment in Africa, researchers ... finding that has implications for how the AIDS virus is ... be given without routine monitoring by lab tests. , But ... to monitor the progression of the disease and guide the ...
    ... , , BERKELEY, Calif., Dec. 9 NeuroFocus, ... two more members to its Advisory Board. , The Advisory ... business and provides NeuroFocus and its clients, many of whom ... , Dr. Hans-Jochen Heinze , Dr. ...
    ... , , , ARLINGTON, Va., Dec. ... Officer of the Healthcare Distribution Management Association (HDMA), issued ... to the Patient Protection and Affordable Care Act, which ... "Importation of prescription drugs from foreign countries, as Senator ...
    ... ... been more compatible…now The Paper Tiger Document Management and Filing System Software is compatible ... ... document management and paper filing system software product is now compatible with ...
    ... ... of software & technology to Home Medical Equipment, Durable Medical Equipment & Home Healthcare ... (Vocus) ... fully automates the financial, clinical and operational aspects of a Home Medical Equipment and ...
    ... Dimes Polls Moms On Their Fears; Doctors Discuss Their Top Concerns ... moms. From the minute they start thinking about whether they want to have ... baby be healthy? Will I be a good mom? Can I dye my ... polled about 1,200 moms to find out exactly what it is that caused ...
    Cached Medicine News:Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 2Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 3Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 2Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 3Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 4Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2
    Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
    0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
    ... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
    16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
    Medicine Products: